MARCHF1 and type 2 diabetes mellitus: Here we performed a GWAS of plasma levels of glucagon during an OGTT in 1899 individuals and identified a previously described type 2 diabetes variant in EYA2, we replicated a previously reported suggestive association with fasting glucagon level and identified a novel genome-wide significant variant, rs4691991 in the MARCH1 locus.